Legend Biotech Corp Stock Book Value Per Share

LEGN Stock  USD 39.75  0.39  0.97%   
Legend Biotech Corp fundamentals help investors to digest information that contributes to Legend Biotech's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend Biotech stock.
Last ReportedProjected for Next Year
Book Value Per Share 7.11  7.46 
Tangible Book Value Per Share 7.08  7.44 
As of the 22nd of November 2024, Book Value Per Share is likely to grow to 7.46. Also, Tangible Book Value Per Share is likely to grow to 7.44.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Legend Biotech Corp Company Book Value Per Share Analysis

Legend Biotech's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

 = 

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Legend Biotech Book Value Per Share

    
  6.08 X  
Most of Legend Biotech's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend Biotech is extremely important. It helps to project a fair market value of Legend Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Legend Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend Biotech's interrelated accounts and indicators.
0.880.910.25-0.92-0.930.78-0.570.780.891.00.770.610.980.930.590.890.980.890.720.85
0.880.980.22-0.95-0.980.69-0.450.590.760.880.670.510.890.770.361.00.911.00.830.91
0.910.980.15-0.95-0.980.76-0.520.630.810.920.760.550.940.830.510.980.960.980.730.9
0.250.220.15-0.43-0.29-0.32-0.340.450.390.24-0.310.550.250.36-0.10.190.250.270.37-0.1
-0.92-0.95-0.95-0.430.98-0.630.63-0.77-0.88-0.91-0.63-0.68-0.93-0.88-0.43-0.95-0.94-0.97-0.78-0.81
-0.93-0.98-0.98-0.290.98-0.720.58-0.71-0.86-0.93-0.71-0.63-0.95-0.87-0.49-0.98-0.96-0.99-0.79-0.89
0.780.690.76-0.32-0.63-0.72-0.550.620.70.770.980.390.760.730.680.720.760.670.440.88
-0.57-0.45-0.52-0.340.630.58-0.55-0.91-0.86-0.54-0.6-0.83-0.6-0.79-0.72-0.46-0.61-0.48-0.14-0.38
0.780.590.630.45-0.77-0.710.62-0.910.930.750.640.850.760.920.630.590.760.610.420.54
0.890.760.810.39-0.88-0.860.7-0.860.930.880.70.760.90.960.730.770.90.780.50.66
1.00.880.920.24-0.91-0.930.77-0.540.750.880.760.590.990.920.590.890.980.890.720.84
0.770.670.76-0.31-0.63-0.710.98-0.60.640.70.760.490.780.760.740.70.780.650.350.83
0.610.510.550.55-0.68-0.630.39-0.830.850.760.590.490.670.830.540.50.670.540.310.37
0.980.890.940.25-0.93-0.950.76-0.60.760.90.990.780.670.950.650.91.00.90.660.83
0.930.770.830.36-0.88-0.870.73-0.790.920.960.920.760.830.950.720.780.940.790.550.71
0.590.360.51-0.1-0.43-0.490.68-0.720.630.730.590.740.540.650.720.390.630.38-0.080.38
0.891.00.980.19-0.95-0.980.72-0.460.590.770.890.70.50.90.780.390.921.00.820.93
0.980.910.960.25-0.94-0.960.76-0.610.760.90.980.780.671.00.940.630.920.920.670.84
0.891.00.980.27-0.97-0.990.67-0.480.610.780.890.650.540.90.790.381.00.920.820.89
0.720.830.730.37-0.78-0.790.44-0.140.420.50.720.350.310.660.55-0.080.820.670.820.78
0.850.910.9-0.1-0.81-0.890.88-0.380.540.660.840.830.370.830.710.380.930.840.890.78
Click cells to compare fundamentals
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Competition

Legend Common Stock Shares Outstanding

Common Stock Shares Outstanding

150.6 Million

At this time, Legend Biotech's Common Stock Shares Outstanding is very stable compared to the past year.
In accordance with the recently published financial statements, the book value per share of Legend Biotech Corp is about 6.084 times. This is 457.88% lower than that of the Biotechnology sector and 102.45% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.69% higher than that of the company.

Legend Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend Biotech's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics of similar companies.
Legend Biotech is currently under evaluation in book value per share category among its peers.

Legend Biotech ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Legend Biotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Legend Biotech's managers, analysts, and investors.
Environmental
Governance
Social

Legend Fundamentals

About Legend Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Legend Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Legend Stock

  0.78VRAX Virax Biolabs GroupPairCorr
  0.77DYN Dyne TherapeuticsPairCorr

Moving against Legend Stock

  0.86PRAX Praxis Precision MedPairCorr
  0.85AMLX Amylyx PharmaceuticalsPairCorr
  0.8EWTX Edgewise TherapeuticsPairCorr
  0.74AKRO Akero TherapeuticsPairCorr
  0.7VRDN Viridian TherapeuticsPairCorr
The ability to find closely correlated positions to Legend Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend Biotech Corp to buy it.
The correlation of Legend Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend Biotech Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out Legend Biotech Piotroski F Score and Legend Biotech Altman Z Score analysis.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.92)
Revenue Per Share
2.851
Quarterly Revenue Growth
0.669
Return On Assets
(0.12)
Return On Equity
(0.28)
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.